Neutrophils: Critical components in experimental animal models of cancer

Seminars in Immunology

Volumn 28, Issue 2, 2016, Pages 197-204

  Hagerling, Catharina ^a   Werb, Zena ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Animal models; Neutrophil; Tumor development

Indexed keywords

ANIMAL MODEL; CIRCULATING TUMOR CELL; DISEASE MODEL; EXPERIMENTAL MODEL; MODEL; NEUTROPHIL; TUMOR GROWTH; TUMOR MODEL; ADAPTIVE IMMUNITY; ANIMAL; DISEASE EXACERBATION; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; METASTASIS; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); NEUTROPHIL CHEMOTAXIS; PATHOLOGY; TUMOR MICROENVIRONMENT;

ADAPTIVE IMMUNITY; ANIMALS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; HUMANS; IMMUNITY, INNATE; NEOPLASM METASTASIS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; NEUTROPHIL INFILTRATION; NEUTROPHILS; TUMOR MICROENVIRONMENT;

EID: 84977914394     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2016.02.003     Document Type: Review

References (132)

1. Sionov R.V., Fridlender Z.G., Granot Z. The multifaceted roles neutrophils play in the tumor microenvironment. Cancer Microenviron. 2015, 3:125-158. (official journal of the International Cancer Microenviron).
2. Swierczak A., Mouchemore K.A., Hamilton J.A., Anderson R.L. Neutrophils: important contributors to tumor progression and metastasis. Cancer Metast. Rev. 2015, 34:735-751.
3. Liang W., Ferrara N. The complex role of neutrophils in tumor angiogenesis and metastasis. Cancer Immunol. Res. 2016, 4:83-91.
4. Fridlender Z.G., Sun J., Kim S., Kapoor V., Cheng G., Ling L., et al. Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN. Cancer Cell 2009, 16:183-194.
5. Eruslanov E.B., Bhojnagarwala P.S., Quatromoni J.G., Stephen T.L., Ranganathan A., Deshpande C., et al. Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer. J. Clin. Invest. 2014, 124:5466-5480.
6. Wu P., Wu D., Ni C., Ye J., Chen W., Hu G., et al. GammadeltaT17 cells promote the accumulation and expansion of myeloid-derived suppressor cells in human colorectal cancer. Immunity 2014, 40:785-800.
7. Mishalian I., Bayuh R., Levy L., Zolotarov L., Michaeli J., Fridlender Z.G. Tumor-associated neutrophils (TAN) develop pro-tumorigenic properties during tumor progression. Cancer Immunol. Immunother.: CII 2013, 62:1745-1756.
8. Elpek K.G., Cremasco V., Shen H., Harvey C.J., Wucherpfennig K.W., Goldstein D.R., et al. The tumor microenvironment shapes lineage, transcriptional, and functional diversity of infiltrating myeloid cells. Cancer Immunol. Res. 2014, 2:655-667.
9. Mestas J., Hughes C.C. Of mice and not men: differences between mouse and human immunology. J. Immunol. 2004, 172:2731-2738.
10. Frese K.K., Tuveson D.A. Maximizing mouse cancer models. Nat. Rev. Cancer 2007, 7:645-658.
11. Haley P.J. Species differences in the structure and function of the immune system. Toxicology 2003, 188:49-71.
12. Rangarajan A., Weinberg R.A. Opinion: comparative biology of mouse versus human cells: modelling human cancer in mice. Nat. Rev. Cancer 2003, 3:952-959.
13. Jonkers J., Berns A. Conditional mouse models of sporadic cancer. Nat. Rev. Cancer 2002, 2:251-265.
14. Maddison K., Clarke A.R. New approaches for modelling cancer mechanisms in the mouse. J. Pathol. 2005, 205:181-193.
15. Politi K., Pao W. How genetically engineered mouse tumor models provide insights into human cancers. J. Clin. Oncol. 2011, 29:2273-2281. (official journal of the J Clin Oncol).
16. Fantozzi A., Christofori G. Mouse models of breast cancer metastasis. Breast Cancer Res.: BCR 2006, 8:212.
17. Eklund L., Bry M., Alitalo K. Mouse models for studying angiogenesis and lymphangiogenesis in cancer. Mol. Oncol. 2013, 7:259-282.
18. Saxena M., Christofori G. Rebuilding cancer metastasis in the mouse. Mol Oncology. 2013, 7:283-296.
19. Dranoff G. Experimental mouse tumour models: what can be learnt about human cancer immunology?. Nat. Rev. Immunol. 2012, 12:61-66.
20. Takeda Y., Costa S., Delamarre E., Roncal C., Leite de Oliveira R., Squadrito M.L., et al. Macrophage skewing by Phd2 haplodeficiency prevents ischaemia by inducing arteriogenesis. Nature 2011, 479:122-126.
21. Finisguerra V., Di Conza G., Di Matteo M., Serneels J., Costa S., Thompson A.A., et al. MET is required for the recruitment of anti-tumoural neutrophils. Nature 2015, 522:349-353.
22. Ito R., Takahashi T., Katano I., Ito M. Current advances in humanized mouse models. Cell. Mol. Immunol. 2012, 9:208-214.
23. Shultz L.D., Brehm M.A., Garcia-Martinez J.V., Greiner D.L. Humanized mice for immune system investigation: progress, promise and challenges. Nat. Rev. Immunol. 2012, 12:786-798.
24. Schmidt M.R., Appel M.C., Giassi L.J., Greiner D.L., Shultz L.D., Woodland R.T. Human BLyS facilitates engraftment of human PBL derived B cells in immunodeficient mice. PLoS ONE 2008, 3:e3192.
25. Danner R., Chaudhari S.N., Rosenberger J., Surls J., Richie T.L., Brumeanu T.D., et al. Expression of HLA class II molecules in humanized NOD, Rag1KO.IL2RgcKO mice is critical for development and function of human T and B cells. PLoS ONE 2011, 6:e19826.
26. Lockridge J.L., Chen X., Zhou Y., Rajesh D., Roenneburg D.A., Hegde S., et al. Analysis of the CD1 antigen presenting system in humanized SCID mice. PLoS ONE 2011, 6:e21701.
27. Rongvaux A., Willinger T., Martinek J., Strowig T., Gearty S.V., Teichmann L.L., et al. Development and function of human innate immune cells in a humanized mouse model. Nat. Biotechol. 2014, 32:364-372.
28. Daley J.M., Thomay A.A., Connolly M.D., Reichner J.S., Albina J.E. Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. J. Leukocyte Biol. 2008, 83:64-70.
29. Fridlender Z.G., Albelda S.M. Tumor-associated neutrophils: friend or foe?. Carcinogenesis 2012, 33:949-955.
30. Gabrilovich D.I., Ostrand-Rosenberg S., Bronte V. Coordinated regulation of myeloid cells by tumours. Nat. Rev. Immunol. 2012, 12:253-268.
31. Peranzoni E., Zilio S., Marigo I., Dolcetti L., Zanovello P., Mandruzzato S., et al. Myeloid-derived suppressor cell heterogeneity and subset definition. Curr. Opin. Immunol. 2010, 22:238-244.
32. Movahedi K., Guilliams M., Van den Bossche J., Van den Bergh R., Gysemans C., Beschin A., et al. Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood 2008, 111:4233-4244.
33. Youn J.I., Nagaraj S., Collazo M., Gabrilovich D.I. Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J. Immunol. 2008, 181:5791-5802.
34. Brandau S., Moses K., Lang S. The kinship of neutrophils and granulocytic myeloid-derived suppressor cells in cancer: cousins, siblings or twins?. Semin. Cancer Biol. 2013, 23:171-182.
35. Haverkamp J.M., Smith A.M., Weinlich R., Dillon C.P., Qualls J.E., Neale G., et al. Myeloid-derived suppressor activity is mediated by monocytic lineages maintained by continuous inhibition of extrinsic and intrinsic death pathways. Immunity 2014, 41:947-959.
36. Dolcetti L., Peranzoni E., Ugel S., Marigo I., Fernandez Gomez A., Mesa C., et al. Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF. Eur. J. Immunol. 2010, 40:22-35.
37. Greifenberg V., Ribechini E., Rossner S., Lutz M.B. Myeloid-derived suppressor cell activation by combined LPS and IFN-gamma treatment impairs DC development. Eur. J. Immunol. 2009, 39:2865-2876.
38. Youn J.I., Collazo M., Shalova I.N., Biswas S.K., Gabrilovich D.I. Characterization of the nature of granulocytic myeloid-derived suppressor cells in tumor-bearing mice. J. Leukocyte Biol. 2012, 91:167-181.
39. Fridlender Z.G., Sun J., Mishalian I., Singhal S., Cheng G., Kapoor V., et al. Transcriptomic analysis comparing tumor-associated neutrophils with granulocytic myeloid-derived suppressor cells and normal neutrophils. PLoS ONE 2012, 7:e31524.
40. Sagiv J.Y., Michaeli J., Assi S., Mishalian I., Kisos H., Levy L., et al. Phenotypic diversity and plasticity in circulating neutrophil subpopulations in cancer. Cell Rep. 2015, 10:562-573.
41. Pillay J., Tak T., Kamp V.M., Koenderman L. Immune suppression by neutrophils and granulocytic myeloid-derived suppressor cells: similarities and differences. Cell. Mol. Life Sci.: CMLS 2013, 70:3813-3827.
42. Elinav E., Nowarski R., Thaiss C.A., Hu B., Jin C., Flavell R.A. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat. Rev. Cancer 2013, 13:759-771.
43. Haqqani A.S., Sandhu J.K., Birnboim H.C. Expression of interleukin-8 promotes neutrophil infiltration and genetic instability in mutatect tumors. Neoplasia 2000, 2:561-568.
44. Gomez-Mejiba S.E., Zhai Z., Gimenez M.S., Ashby M.T., Chilakapati J., Kitchin K., et al. Myeloperoxidase-induced genomic DNA-centered radicals. J. Biol. Chem. 2010, 285:20062-20071.
45. Gungor N., Knaapen A.M., Munnia A., Peluso M., Haenen G.R., Chiu R.K., et al. Genotoxic effects of neutrophils and hypochlorous acid. Mutagenesis 2010, 25:149-154.
46. Sandhu J.K., Privora H.F., Wenckebach G., Birnboim H.C. Neutrophils, nitric oxide synthase, and mutations in the mutatect murine tumor model. Am. J. Pathol. 2000, 156:509-518.
47. Wilkinson D., Sandhu J.K., Breneman J.W., Tucker J.D., Birnboim H.C. Hprt mutants in a transplantable murine tumour arise more frequently in vivo than in vitro. Br. J. Cancer 1995, 72:1234-1240.
48. Lakatos P.L., Lakatos L. Risk for colorectal cancer in ulcerative colitis: changes, causes and management strategies. World J. Gastroenterol. 2008, 14:3937-3947.
49. Okayasu I., Hatakeyama S., Yamada M., Ohkusa T., Inagaki Y., Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990, 98:694-702.
50. Tanaka T., Kohno H., Suzuki R., Yamada Y., Sugie S., Mori H. A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate. Cancer Sci. 2003, 94:965-973.
51. Shang K., Bai Y.P., Wang C., Wang Z., Gu H.Y., Du X., et al. Crucial involvement of tumor-associated neutrophils in the regulation of chronic colitis-associated carcinogenesis in mice. PLoS ONE 2012, 7:e51848.
52. Katoh H., Wang D., Daikoku T., Sun H., Dey S.K., Dubois R.N. CXCR2-expressing myeloid-derived suppressor cells are essential to promote colitis-associated tumorigenesis. Cancer Cell 2013, 24:631-644.
53. Jamieson T., Clarke M., Steele C.W., Samuel M.S., Neumann J., Jung A., et al. Inhibition of CXCR2 profoundly suppresses inflammation-driven and spontaneous tumorigenesis. J. Clin. Invest. 2012, 122:3127-3144.
54. Mueller M.M. Inflammation in epithelial skin tumours: old stories and new ideas. Eur. J. Cancer 2006, 42:735-744.
55. Vesely M.D., Kershaw M.H., Schreiber R.D., Smyth M.J. Natural innate and adaptive immunity to cancer. Annu. Rev. Immunol. 2011, 29:235-271.
56. Shankaran V., Ikeda H., Bruce A.T., White J.M., Swanson P.E., Old L.J., et al. IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 2001, 410:1107-1111.
57. Girardi M., Oppenheim D.E., Steele C.R., Lewis J.M., Glusac E., Filler R., et al. Regulation of cutaneous malignancy by gammadelta T cells. Science 2001, 294:605-609.
58. Aruga A., Aruga E., Cameron M.J., Chang A.E. Different cytokine profiles released by CD4+ and CD8+ tumor-draining lymph node cells involved in mediating tumor regression. J. Leukocyte Biol. 1997, 61:507-516.
59. Bronte V., Zanovello P. Regulation of immune responses by l-arginine metabolism. Nat. Rev. Immunol. 2005, 5:641-654.
60. Jaillon S., Galdiero M.R., Del Prete D., Cassatella M.A., Garlanda C., Mantovani A. Neutrophils in innate and adaptive immunity. Semin. Immunopathol. 2013, 35:377-394.
61. Richards H., Williams A., Jones E., Hindley J., Godkin A., Simon A.K., et al. Novel role of regulatory T cells in limiting early neutrophil responses in skin. Immunology 2010, 131:583-592.
62. Neville M.E., Pezzella K.M., Schmidt K., Galbraith W., Ackerman N. In vivo inhibition of tumor growth of B16 melanoma by recombinant interleukin 1 beta. II. Mechanism of inhibition: the role of polymorphonuclear leukocytes. Cytokine 1990, 2:456-463.
63. Souto J.C., Vila L., Bru A. Polymorphonuclear neutrophils and cancer: intense and sustained neutrophilia as a treatment against solid tumors. Med. Res. Rev. 2011, 31:311-363.
64. Grivennikov S.I., Karin M. Inflammation and oncogenesis: a vicious connection. Curr. Opin. Gen. Dev. 2010, 20:65-71.
65. Antonio N., Bonnelykke-Behrndtz M.L., Ward L.C., Collin J., Christensen I.J., Steiniche T., et al. The wound inflammatory response exacerbates growth of pre-neoplastic cells and progression to cancer. EMBO J. 2015, 34:2219-2236.
66. White R., Rose K., Zon L. Zebrafish cancer: the state of the art and the path forward. Nat. Rev. Cancer 2013, 13:624-636.
67. Harvie E.A., Huttenlocher A. Neutrophils in host defense: new insights from zebrafish. J. Leukocyte Biol. 2015, 98:523-537.
68. Shelef M.A., Tauzin S., Huttenlocher A. Neutrophil migration: moving from zebrafish models to human autoimmunity. Immunol. Rev. 2013, 256:269-281.
69. Feng Y., Martin P. Imaging innate immune responses at tumour initiation: new insights from fish and flies. Nat. Rev. Cancer 2015, 15:556-562.
70. Lieschke G.J., Oates A.C., Crowhurst M.O., Ward A.C., Layton J.E. Morphologic and functional characterization of granulocytes and macrophages in embryonic and adult zebrafish. Blood 2001, 98:3087-3096.
71. Le Guyader D., Redd M.J., Colucci-Guyon E., Murayama E., Kissa K., Briolat V., et al. Origins and unconventional behavior of neutrophils in developing zebrafish. Blood 2008, 111:132-141.
72. Lam S.H., Chua H.L., Gong Z., Lam T.J., Sin Y.M. Development and maturation of the immune system in zebrafish, Danio rerio: a gene expression profiling, in situ hybridization and immunological study. Dev. Comp. Immunol. 2004, 28:9-28.
73. Michailidou C., Jones M., Walker P., Kamarashev J., Kelly A., Hurlstone A.F. Dissecting the roles of Raf- and PI3K-signalling pathways in melanoma formation and progression in a zebrafish model. Dis. Model Mech. 2009, 2:399-411.
74. Feng Y., Renshaw S., Martin P. Live imaging of tumor initiation in zebrafish larvae reveals a trophic role for leukocyte-derived PGE(2). Curr. Biol. 2012, 22:1253-1259.
75. Feng Y., Santoriello C., Mione M., Hurlstone A., Martin P. Live imaging of innate immune cell sensing of transformed cells in zebrafish larvae: parallels between tumor initiation and wound inflammation. PLoS Biol. 2010, 8:e1000562.
76. Collado M., Serrano M. Senescence in tumours: evidence from mice and humans. Nat. Rev. Cancer 2010, 10:51-57.
77. Chen Z., Trotman L.C., Shaffer D., Lin H.K., Dotan Z.A., Niki M., et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 2005, 436:725-730.
78. Alimonti A., Nardella C., Chen Z., Clohessy J.G., Carracedo A., Trotman L.C., et al. A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis. J. Clin. Invest. 2010, 120:681-693.
79. + myeloid cells antagonize senescence in cancer. Nature 2014, 515:134-137.
80. Distler M., Aust D., Weitz J., Pilarsky C., Grutzmann R. Precursor lesions for sporadic pancreatic cancer: PanIN, IPMN, and MCN. BioMed Res. Int. 2014, 2014:474905.
81. Hingorani S.R., Petricoin E.F., Maitra A., Rajapakse V., King C., Jacobetz M.A., et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 2003, 4:437-450.
82. Pylayeva-Gupta Y., Lee K.E., Hajdu C.H., Miller G., Bar-Sagi D. Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia. Cancer Cell 2012, 21:836-847.
83. Bayne L.J., Beatty G.L., Jhala N., Clark C.E., Rhim A.D., Stanger B.Z., et al. Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer. Cancer Cell 2012, 21:822-835.
84. Casbon A.J., Reynaud D., Park C., Khuc E., Gan D.D., Schepers K., et al. Invasive breast cancer reprograms early myeloid differentiation in the bone marrow to generate immunosuppressive neutrophils. Proc. Natl. Acad. Sci. U.S.A. 2015, 112:E566-E575.
85. Guy C.T., Cardiff R.D., Muller W.J. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol. Cell. Biol. 1992, 12:954-961.
86. Guy C.T., Webster M.A., Schaller M., Parsons T.J., Cardiff R.D., Muller W.J. Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:10578-10582.
87. Melani C., Chiodoni C., Forni G., Colombo M.P. Myeloid cell expansion elicited by the progression of spontaneous mammary carcinomas in c-erbB-2 transgenic BALB/c mice suppresses immune reactivity. Blood 2003, 102:2138-2145.
88. Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin. Oncol. 2002, 29:15-18.
89. Bergers G., Benjamin L.E. Tumorigenesis and the angiogenic switch. Nat. Rev. Cancer 2003, 3:401-410.
90. Tazzyman S., Niaz H., Murdoch C. Neutrophil-mediated tumour angiogenesis: subversion of immune responses to promote tumour growth. Semin. Cancer Biol. 2013, 23:149-158.
91. Scapini P., Morini M., Tecchio C., Minghelli S., Di Carlo E., Tanghetti E., et al. CXCL1/macrophage inflammatory protein-2-induced angiogenesis in vivo is mediated by neutrophil-derived vascular endothelial growth factor-A. J. Immunol. 2004, 172:5034-5040. (i).
92. Nozawa H., Chiu C., Hanahan D. Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:12493-12498.
93. Hanahan D. Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. Nature 1985, 315:115-122.
94. Deryugina E.I., Zajac E., Juncker-Jensen A., Kupriyanova T.A., Welter L., Quigley J.P. Tissue-infiltrating neutrophils constitute the major in vivo source of angiogenesis-inducing MMP-9 in the tumor microenvironment. Neoplasia 2014, 16:771-788.
95. Murphy G. Tissue inhibitors of metalloproteinases. Genome Biol. 2011, 12:233.
96. Ardi V.C., Van den Steen P.E., Opdenakker G., Schweighofer B., Deryugina E.I., Quigley J.P. Neutrophil MMP-9 proenzyme, unencumbered by TIMP-1, undergoes efficient activation in vivo and catalytically induces angiogenesis via a basic fibroblast growth factor (FGF-2)/FGFR-2 pathway. J. Biol. Chem. 2009, 284:25854-25866.
97. Bekes E.M., Schweighofer B., Kupriyanova T.A., Zajac E., Ardi V.C., Quigley J.P., et al. Tumor-recruited neutrophils and neutrophil TIMP-free MMP-9 regulate coordinately the levels of tumor angiogenesis and efficiency of malignant cell intravasation. Am. J. Pathol. 2011, 179:1455-1470.
98. Bergers G., Brekken R., McMahon G., Vu T.H., Itoh T., Tamaki K., et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat. Cell Biol. 2000, 2:737-744.
99. Bonnans C., Chou J., Werb Z. Remodelling the extracellular matrix in development and disease. Nat. Rev. Mol. Cell Biol. 2014, 15:786-801.
100. Bausch D., Pausch T., Krauss T., Hopt U.T., Fernandez-del-Castillo C., Warshaw A.L., et al. Neutrophil granulocyte derived MMP-9 is a VEGF independent functional component of the angiogenic switch in pancreatic ductal adenocarcinoma. Angiogenesis 2011, 14:235-243.
101. Shojaei F., Wu X., Zhong C., Yu L., Liang X.H., Yao J., et al. Bv8 regulates myeloid-cell-dependent tumour angiogenesis. Nature 2007, 450:825-831.
102. Shojaei F., Singh M., Thompson J.D., Ferrara N. Role of Bv8 in neutrophil-dependent angiogenesis in a transgenic model of cancer progression. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:2640-2645.
103. Jablonska J., Leschner S., Westphal K., Lienenklaus S., Weiss S. Neutrophils responsive to endogenous IFN-beta regulate tumor angiogenesis and growth in a mouse tumor model. J. Clin. Invest. 2010, 120:1151-1164.
104. Jablonska J., Wu C.F., Andzinski L., Leschner S., Weiss S. CXCR2-mediated tumor-associated neutrophil recruitment is regulated by IFN-beta. Int. J. Cancer 2014, 134:1346-1358.
105. Shinkai Y., Rathbun G., Lam K.P., Oltz E.M., Stewart V., Mendelsohn M., et al. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 1992, 68:855-867.
106. Andzinski L., Wu C.F., Lienenklaus S., Kroger A., Weiss S., Jablonska J. Delayed apoptosis of tumor associated neutrophils in the absence of endogenous IFN-beta. Int. J. Cancer 2015, 136:572-583.
107. + myeloid cells that promote metastasis. Cancer Cell 2008, 13:23-35.
108. Kato M., Takahashi M., Akhand A.A., Liu W., Dai Y., Shimizu S., et al. Transgenic mouse model for skin malignant melanoma. Oncogene 1998, 17:1885-1888.
109. Toh B., Wang X., Keeble J., Sim W.J., Khoo K., Wong W.C., et al. Mesenchymal transition and dissemination of cancer cells is driven by myeloid-derived suppressor cells infiltrating the primary tumor. PLoS Biol. 2011, 9:e1001162.
110. Bald T., Quast T., Landsberg J., Rogava M., Glodde N., Lopez-Ramos D., et al. Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma. Nature 2014, 507:109-113.
111. + myeloid cells tip the balance of immune protection to tumor promotion in the premetastatic lung. Cancer Res. 2010, 70:6139-6149.
112. Cedervall J., Zhang Y., Huang H., Zhang L., Femel J., Dimberg A., et al. Neutrophil extracellular traps accumulate in peripheral blood vessels and compromise organ function in tumor-bearing animals. Cancer Res. 2015, 75:2653-2662.
113. Wculek S.K., Malanchi I. Neutrophils support lung colonization of metastasis-initiating breast cancer cells. Nature 2015, 528:413-417.
114. Sceneay J., Smyth M.J., Moller A. The pre-metastatic niche: finding common ground. Cancer Metast. Rev. 2013, 32:449-464.
115. + immune suppressor cells and compromises NK cell cytotoxicity in the premetastatic niche. Cancer Res. 2012, 72:3906-3911.
116. Liu Y., Kosaka A., Ikeura M., Kohanbash G., Fellows-Mayle W., Snyder L.A., et al. Premetastatic soil and prevention of breast cancer brain metastasis. Neuro-oncology 2013, 15:891-903.
117. + granulocytes. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:21248-21255.
118. Huh S.J., Liang S., Sharma A., Dong C., Robertson G.P. Transiently entrapped circulating tumor cells interact with neutrophils to facilitate lung metastasis development. Cancer Res. 2010, 70:6071-6082.
119. Spicer J.D., McDonald B., Cools-Lartigue J.J., Chow S.C., Giannias B., Kubes P., et al. Neutrophils promote liver metastasis via Mac-1-mediated interactions with circulating tumor cells. Cancer Res. 2012, 72:3919-3927.
120. Cools-Lartigue J., Spicer J., McDonald B., Gowing S., Chow S., Giannias B., et al. Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis. J. Clin. Invest. 2013, 8:3446-3458.
121. Lopez-Lago M.A., Posner S., Thodima V.J., Molina A.M., Motzer R.J., Chaganti R.S. Neutrophil chemokines secreted by tumor cells mount a lung antimetastatic response during renal cell carcinoma progression. Oncogene 2013, 32:1752-1760.
122. Granot Z., Henke E., Comen E.A., King T.A., Norton L., Benezra R. Tumor entrained neutrophils inhibit seeding in the premetastatic lung. Cancer Cell. 2011, 20:300-314.
123. Chattopadhyay P.K., Gierahn T.M., Roederer M., Love J.C. Single-cell technologies for monitoring immune systems. Nat. Immunol. 2014, 15:128-135.
124. Shapiro E., Biezuner T., Linnarsson S. Single-cell sequencing-based technologies will revolutionize whole-organism science. Nat. Rev. Genet. 2013, 14:618-630.
125. Derksen P.W., Liu X., Saridin F., van der Gulden H., Zevenhoven J., Evers B., et al. Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis. Cancer Cell. 2006, 10:437-449.
126. Coffelt S.B., Kersten K., Doornebal C.W., Weiden J., Vrijland K., Hau C.S., et al. IL-17-producing gammadelta T cells and neutrophils conspire to promote breast cancer metastasis. Nature 2015, 522:345-348.
127. Mathias J.R., Perrin B.J., Liu T.X., Kanki J., Look A.T., Huttenlocher A. Resolution of inflammation by retrograde chemotaxis of neutrophils in transgenic zebrafish. J. Leukocyte Biol. 2006, 80:1281-1288.
128. Buckley C.D., Ross E.A., McGettrick H.M., Osborne C.E., Haworth O., Schmutz C., et al. Identification of a phenotypically and functionally distinct population of long-lived neutrophils in a model of reverse endothelial migration. J. Leukocyte Biol. 2006, 79:303-311.
129. Woodfin A., Voisin M.B., Beyrau M., Colom B., Caille D., Diapouli F.M., et al. The junctional adhesion molecule JAM-C regulates polarized transendothelial migration of neutrophils in vivo. Nat. Immunol. 2011, 12:761-769.
130. Hasenberg A., Hasenberg M., Mann L., Neumann F., Borkenstein L., Stecher M., et al. Catchup: a mouse model for imaging-based tracking and modulation of neutrophil granulocytes. Nat. Methods 2015, 12:445-452.
131. Sanchez-Rivera F.J., Jacks T. Applications of the CRISPR-Cas9 system in cancer biology. Nat. Rev. Cancer 2015, 15:387-395.
132. Mou H., Kennedy Z., Anderson D.G., Yin H., Xue W. Precision cancer mouse models through genome editing with CRISPR-Cas9. Genome Med. 2015, 7:53.